These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5577288)

  • 21. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
    Sachse A; Verboom CN; Jäger B
    J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experiences with the new antihypertensive agent Catapresan].
    Messerich J
    Med Klin; 1966 Dec; 61(52):2078-9. PubMed ID: 5999213
    [No Abstract]   [Full Text] [Related]  

  • 23. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical studies on the antihypertensive effect of Catapresan].
    Kreuziger H; Brehm H
    Med Welt; 1968 Apr; 14():905-7. PubMed ID: 5718198
    [No Abstract]   [Full Text] [Related]  

  • 25. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term treatment with a new antihypertensive drug: flutonidin].
    Nicrosini F; Pasotti C
    Minerva Med; 1983 May; 74(21):1297-300. PubMed ID: 6406947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
    Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
    J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of losartan on haematology and haemorheology in elderly patients with essential hypertension: a pilot study.
    Shand BI; Gilchrist NL; Nicholls MG; Bailey RR
    J Hum Hypertens; 1995 Apr; 9(4):233-5. PubMed ID: 7595904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
    Haenni A; Lithell H
    J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 34. New angiotensin-II blocker.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Mar; 96(3):20. PubMed ID: 8607540
    [No Abstract]   [Full Text] [Related]  

  • 35. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of valvular regurgitation during long-term antihypertensive therapy in patients with mild to moderate essential hypertension].
    Takaoka N; Tomiyama H; Yoshida H; Doba N
    J Cardiol; 1997 Apr; 29(4):209-16. PubMed ID: 9127837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of phisiotens for the treatment of arterial hypertension in elderly patients].
    Ostroumova OD; Mamaev VI; Bagramova IuA; Rybkina TE; Kuz'michev IA
    Ter Arkh; 2001; 73(9):17-22. PubMed ID: 11642073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of a new angiotensin II type 1 receptor blocker, pratosartan, in hypertensive patients.
    Ogihara T; Saruta T; Shimamoto K; Matsuoka H; Rakugi H
    Hypertens Res; 2008 Feb; 31(2):281-7. PubMed ID: 18360048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
    Zamotaev IuN; Enikeev AKh; Kolomoets NM
    Klin Med (Mosk); 2009; 87(6):46-9. PubMed ID: 19670717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.